Ultralife Statistics
Total Valuation
Ultralife has a market cap or net worth of $82.75 million. The enterprise value is $129.78 million.
Important Dates
The next confirmed earnings date is Friday, May 9, 2025, before market open.
| Earnings Date | May 9, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Ultralife has 16.63 million shares outstanding. The number of shares has increased by 2.97% in one year.
| Current Share Class | 16.63M |
| Shares Outstanding | 16.63M |
| Shares Change (YoY) | +2.97% |
| Shares Change (QoQ) | -0.49% |
| Owned by Insiders (%) | 35.99% |
| Owned by Institutions (%) | 41.09% |
| Float | 10.65M |
Valuation Ratios
The trailing PE ratio is 12.84.
| PE Ratio | 12.84 |
| Forward PE | n/a |
| PS Ratio | 0.49 |
| Forward PS | 0.36 |
| PB Ratio | 0.61 |
| P/TBV Ratio | 1.21 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 24.55 |
| EV / Sales | 0.75 |
| EV / EBITDA | 9.59 |
| EV / EBIT | 13.95 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.22, with a Debt / Equity ratio of 0.42.
| Current Ratio | 3.22 |
| Quick Ratio | 1.42 |
| Debt / Equity | 0.42 |
| Debt / EBITDA | 3.89 |
| Debt / FCF | n/a |
| Interest Coverage | 4.79 |
Financial Efficiency
Return on equity (ROE) is 4.05% and return on invested capital (ROIC) is 3.31%.
| Return on Equity (ROE) | 4.05% |
| Return on Assets (ROA) | 2.88% |
| Return on Invested Capital (ROIC) | 3.31% |
| Return on Capital Employed (ROCE) | 4.84% |
| Revenue Per Employee | $258,234 |
| Profits Per Employee | $7,878 |
| Employee Count | 671 |
| Asset Turnover | 0.86 |
| Inventory Turnover | 2.83 |
Taxes
In the past 12 months, Ultralife has paid $1.76 million in taxes.
| Income Tax | 1.76M |
| Effective Tax Rate | 24.59% |
Stock Price Statistics
The stock price has decreased by -62.10% in the last 52 weeks. The beta is 0.77, so Ultralife's price volatility has been lower than the market average.
| Beta (5Y) | 0.77 |
| 52-Week Price Change | -62.10% |
| 50-Day Moving Average | 5.04 |
| 200-Day Moving Average | 7.73 |
| Relative Strength Index (RSI) | 56.35 |
| Average Volume (20 Days) | 62,458 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Ultralife had revenue of $173.28 million and earned $5.29 million in profits. Earnings per share was $0.31.
| Revenue | 173.28M |
| Gross Profit | 43.59M |
| Operating Income | 9.30M |
| Pretax Income | 12.33M |
| Net Income | 5.29M |
| EBITDA | 13.53M |
| EBIT | 9.30M |
| Earnings Per Share (EPS) | $0.31 |
Full Income StatementBalance Sheet
The company has $8.72 million in cash and $57.33 million in debt, giving a net cash position of -$48.62 million or -$2.92 per share.
| Cash & Cash Equivalents | 8.72M |
| Total Debt | 57.33M |
| Net Cash | -48.62M |
| Net Cash Per Share | -$2.92 |
| Equity (Book Value) | 136.60M |
| Book Value Per Share | 8.20 |
| Working Capital | 69.97M |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 25.16%, with operating and profit margins of 5.37% and 3.05%.
| Gross Margin | 25.16% |
| Operating Margin | 5.37% |
| Pretax Margin | 4.12% |
| Profit Margin | 3.05% |
| EBITDA Margin | 7.81% |
| EBIT Margin | 5.37% |
| FCF Margin | n/a |